Risk of carotid atherosclerosis is associated with low serum paraoxonase (PON1) activity among arsenic exposed residents in Southwestern Taiwan

Barchowsky, 1999, Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite, Free Radic. Biol. Med., 27, 1405, 10.1016/S0891-5849(99)00186-0 Benichou, 2001, A review of adjusted estimators of attributable risk, Stat. Methods Med. Res., 10, 195, 10.1177/096228020101000303 Bhattacharyya, 2008, Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk, JAMA, 299, 1265, 10.1001/jama.299.11.1265 Brophy, 2001, Polymorphisms in the human paraoxonase (PON1) promoter, Pharmacogenetics, 11, 77, 10.1097/00008571-200102000-00009 Bruzzi, 1985, Estimating the population attributable risk for multiple risk factors using case-control data, Am. J. Epidemiol., 122, 904, 10.1093/oxfordjournals.aje.a114174 Chen, 1996, Dose–response relationship between ischemic heart disease mortality and long-term arsenic exposure, Arterioscler. Thromb. Vasc. Biol., 16, 504, 10.1161/01.ATV.16.4.504 Chen, 1995, Increased prevalence of hypertension and long-term arsenic exposure, Hypertension, 25, 53, 10.1161/01.HYP.25.1.53 Chen, 2003, Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study, Am. J. Hum. Genet., 72, 13, 10.1086/345312 Chen, 1998, Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis, J. Cell Physiol., 177, 324, 10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9 Chiou, 1997, Dose–response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic, Stroke, 28, 1717, 10.1161/01.STR.28.9.1717 Christiansen, 2004, Paraoxonase 1 polymorphisms and survival, Eur. J. Hum. Genet., 12, 843, 10.1038/sj.ejhg.5201235 Cole, 2002, Inhibition of paraoxonase (PON1) by heavy metals, Toxicol. Sci., 66, 312 de Groot, 2004, Measurement of arterial wall thickness as a surrogate marker for atherosclerosis, Circulation, 109, III33, 10.1161/01.CIR.0000131516.65699.ba Hegele, 1997, Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus, J. Clin. Endocrinol. Metab., 82, 3373 Hegele, 1998, Genetic variation in paraoxonase-2 is associated with variation in plasma lipoproteins in Canadian Oji-Cree, Clin. Genet., 54, 394, 10.1111/j.1399-0004.1998.tb03752.x Humbert, 1993, The molecular basis of the human serum paraoxonase activity polymorphism, Nat. Genet., 3, 73, 10.1038/ng0193-73 Jarvik, 2000, Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype, Arterioscler. Thromb. Vasc. Biol., 20, 2441, 10.1161/01.ATV.20.11.2441 Kuo, 1964, Arsenic content of artesian well water in endemic area of chronic arsenic poisoning, Rep. Inst. Pathol. Coll. Med. Natl. Taiwan Univ., 20, 7 Lee, 2005, Oxidative stress mediates sodium arsenite-induced expression of heme oxygenase-1, monocyte chemoattractant protein-1, and interleukin-6 in vascular smooth muscle cells, Toxicol. Sci., 85, 541, 10.1093/toxsci/kfi101 Leus, 2001, PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients, Atherosclerosis, 154, 641, 10.1016/S0021-9150(00)00440-8 Li, 2006, Lead exposure is associated with decreased serum paraoxonase 1 (PON1) activity and genotypes, Environ. Health Perspect., 114, 1233, 10.1289/ehp.9163 Lo, 1977, 1 Lorenz, 2007, Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis, Circulation, 115, 459, 10.1161/CIRCULATIONAHA.106.628875 Mackness, 2001, Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?, Arterioscler. Thromb. Vasc. Biol., 21, 1451, 10.1161/hq0901.094247 Mackness, 2003, Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study, Circulation, 107, 2775, 10.1161/01.CIR.0000070954.00271.13 Mochizuki, 1998, Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence, Gene, 213, 149, 10.1016/S0378-1119(98)00193-0 Navas-Acien, 2005, Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence, Am. J. Epidemiol., 162, 1037, 10.1093/aje/kwi330 Ng, 2006, Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2, J. Biol. Chem., 281, 29491, 10.1074/jbc.M605379200 Pan, 2002, The risk of coronary artery disease in population of Taiwan is associated with Cys-Ser 311 polymorphism of human paraoxonase (PON)-2 gene, Zhonghua Yi Xue Za Zhi (Taipei), 65, 415 Pi, 2002, Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water, Environ. Health Perspect., 110, 331, 10.1289/ehp.02110331 Shih, 1998, Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis, Nature, 394, 284, 10.1038/28406 States, 2009, Arsenic and cardiovascular disease, Toxicol. Sci., 107, 312, 10.1093/toxsci/kfn236 Su, 2005, Paraoxonase gene cluster variations associated with coronary heart disease in Chinese Han women, Chin. Med. J., 118, 1167 Tseng, 1996, Dose–response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan, Atherosclerosis, 120, 125, 10.1016/0021-9150(95)05693-9 Tseng, 2005, Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan, Toxicol. Appl. Pharmacol., 206, 299, 10.1016/j.taap.2004.11.022 Tward, 2002, Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice, Circulation, 106, 484, 10.1161/01.CIR.0000023623.87083.4F Wang, 2002, Biological gradient between long-term arsenic exposure and carotid atherosclerosis, Circulation, 105, 1804, 10.1161/01.CIR.0000015862.64816.B2 Wang, 1996, Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species, J. Cell. Physiol., 169, 256, 10.1002/(SICI)1097-4652(199611)169:2<256::AID-JCP5>3.0.CO;2-N Wang, 2003, Extensive association analysis between polymorphisms of PON gene cluster with coronary heart disease in Chinese Han population, Arterioscler. Thromb. Vasc. Biol., 23, 328, 10.1161/01.ATV.0000051702.38086.C1 Wang, 2007, Effects of arsenic exposure and genetic polymorphisms of p53, glutathione S-transferase M1, T1, and P1 on the risk of carotid atherosclerosis in Taiwan, Atherosclerosis, 192, 305, 10.1016/j.atherosclerosis.2006.07.029 Wheeler, 2004, Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies, Lancet, 363, 689, 10.1016/S0140-6736(04)15642-0 Wu, 2003, Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects, Environ. Health Perspect., 111, 1429, 10.1289/ehp.6396 Wu, 2001, Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan, Environ. Health Perspect., 109, 1011, 10.1289/ehp.011091011